Bill McHughNailed It — My Current StatusA quick update on my current status. I’ve saved the gross pictures till the end, so you can look away if needed! My Multiple Myeloma is…May 21
Michael Hunter, MDinBeingWellBreakthrough: New Treatment Sparks Remarkable, Swift Reversal of Brain Cancer in Early Clinical…GLIOBLASTOMA IS AN AGGRESSIVE BRAIN CANCER that forms from star-shaped cells known as astrocytes. It is the most common and most aggressive…Mar 283
ITIFinInnovate4HealthCaring Cross and Brazil’s Fundação Oswaldo Cruz Collaboration Increases Access to Life-Saving CAR-T…This post is one of a series in the #Innovate4Health policy research initiative. #Innovate4Health is a joint research project by the…May 15May 15
The Leukemia & Lymphoma SocietyCAR T-cell Therapy Approved for Initial Treatment of Relapsed Large B-cell LymphomaBy Lee Greenberger, PhD, Chief Scientific Officer at LLS | April 5, 2022Apr 5, 20221Apr 5, 20221
ScienceStyledArtemis and the Accidental Enlightenment: A Comical Tale of Discovery in Modern MedicineI am Artemis, erstwhile goddess of the hunt, now reimagined as a scribe of the sciences, recounting the most unexpected prelude to my…Apr 17Apr 17
Bill McHughNailed It — My Current StatusA quick update on my current status. I’ve saved the gross pictures till the end, so you can look away if needed! My Multiple Myeloma is…May 21
Michael Hunter, MDinBeingWellBreakthrough: New Treatment Sparks Remarkable, Swift Reversal of Brain Cancer in Early Clinical…GLIOBLASTOMA IS AN AGGRESSIVE BRAIN CANCER that forms from star-shaped cells known as astrocytes. It is the most common and most aggressive…Mar 283
ITIFinInnovate4HealthCaring Cross and Brazil’s Fundação Oswaldo Cruz Collaboration Increases Access to Life-Saving CAR-T…This post is one of a series in the #Innovate4Health policy research initiative. #Innovate4Health is a joint research project by the…May 15
The Leukemia & Lymphoma SocietyCAR T-cell Therapy Approved for Initial Treatment of Relapsed Large B-cell LymphomaBy Lee Greenberger, PhD, Chief Scientific Officer at LLS | April 5, 2022Apr 5, 20221
ScienceStyledArtemis and the Accidental Enlightenment: A Comical Tale of Discovery in Modern MedicineI am Artemis, erstwhile goddess of the hunt, now reimagined as a scribe of the sciences, recounting the most unexpected prelude to my…Apr 17
The Leukemia & Lymphoma SocietyFDA Approves First CAR T-Immunotherapy for Relapsed/Refractory Acute Lymphoblastic LeukemiaThe U.S. Food and Drug Administration (FDA) recently announced approval of brexucabtagene autoleucel (Tecartus®) as the first and only CAR…Nov 11, 2021
Aditi BhargavaGene Therapy: Nature Versus ManWith the advent of cutting-edge genome editing technologies such as CRISPR and the use of RNA moieties for modulation of cell function, it…Feb 151
Previtha DawnMobilising T cells against cancerThe first step in manufacturing T cell immunotherapies against cancer is T cell activation.Feb 1, 2021
